Insider Transactions in Q2 2025 at Liquidia Corp (LQDA)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2025
|
Stephen M Bloch Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,396
+32.19%
|
-
|
|
Jun 17
2025
|
Damian De Goa Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,396
+17.54%
|
-
|
|
Jun 17
2025
|
Joanna Horobin Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,396
+32.19%
|
-
|
|
Jun 17
2025
|
Arthur S Kirsch Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,396
+31.1%
|
-
|
|
Jun 17
2025
|
Paul B Manning Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,396
+32.19%
|
-
|
|
Jun 17
2025
|
Katherine Rielly Gauvin Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,396
+32.19%
|
-
|
|
Jun 17
2025
|
Raman Singh Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,396
+32.19%
|
-
|
|
Jun 17
2025
|
David Edward Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,396
+32.19%
|
-
|
|
Jun 04
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,597
-2.71%
|
$121,552
$16.97 P/Share
|
|
Jun 04
2025
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,656
-2.87%
|
$106,496
$16.97 P/Share
|
|
Jun 04
2025
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
8,460
-1.43%
|
$135,360
$16.97 P/Share
|
|
Jun 04
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,597
-1.82%
|
$57,552
$16.97 P/Share
|
|
Jun 04
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
14,777
-3.46%
|
$236,432
$16.97 P/Share
|
|
Jun 04
2025
|
Roger Jeffs Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,610
-2.85%
|
$489,760
$16.97 P/Share
|
|
Jun 03
2025
|
Rajeev Saggar Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,654
+5.92%
|
-
|
|
Jun 03
2025
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,539
+6.29%
|
-
|
|
Jun 03
2025
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
18,792
+3.08%
|
-
|
|
Jun 03
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,371
+5.9%
|
-
|
|
Jun 03
2025
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
29,141
+6.39%
|
-
|
|
Jun 03
2025
|
Roger Jeffs Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
69,169
+6.04%
|
-
|
|
Jun 02
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
859
-0.22%
|
$13,744
$16.74 P/Share
|
|
Jun 02
2025
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
581
-0.27%
|
$9,296
$16.74 P/Share
|
|
Jun 02
2025
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
923
-0.16%
|
$14,768
$16.74 P/Share
|
|
Jun 02
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
451
-0.24%
|
$7,216
$16.74 P/Share
|
|
May 30
2025
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.58%
|
-
|
|
May 30
2025
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+0.86%
|
-
|
|
May 30
2025
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.41%
|
-
|
|
May 30
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,563
+0.84%
|
-
|
|
Apr 28
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
455
-0.25%
|
$6,370
$14.24 P/Share
|
|
Apr 21
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,450
-0.92%
|
$31,850
$13.67 P/Share
|
|
Apr 15
2025
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,406
-1.56%
|
$44,278
$13.57 P/Share
|
|
Apr 14
2025
|
Roger Jeffs Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,130
-1.38%
|
$183,690
$13.57 P/Share
|
|
Apr 14
2025
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
5,964
-1.03%
|
$77,532
$13.57 P/Share
|
|
Apr 14
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,714
-1.38%
|
$48,282
$13.57 P/Share
|
|
Apr 14
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
8,283
-2.05%
|
$107,679
$13.57 P/Share
|
|
Apr 14
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,856
-1.0%
|
$24,128
$13.57 P/Share
|
|
Apr 11
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,906
+2.06%
|
-
|